RT Journal Article
T1 Factors associated with 30-day readmission after hospitalisation for community-acquired pneumonia in older patients: a cross-sectional study in seven Spanish regions.
A1 Toledo, Diana
A1 Soldevila, Núria
A1 Torner, Núria
A1 Pérez-Lozano, María José
A1 Espejo, Elena
A1 Navarro, Gemma
A1 Egurrola, Mikel
A1 Domínguez, Ángela
A1 On-behalf of the Project FIS PI12/02079 Working Group, 
K1 community acquired pneumonia
K1 elderly
K1 infectious diseases
K1 readmission
AB Hospital readmission in patients admitted for community-acquired pneumonia (CAP) is frequent in the elderly and patients with multiple comorbidities, resulting in a clinical and economic burden. The aim of this study was to determine factors associated with 30-day readmission in patients with CAP. A cross-sectional study. The study was conducted in patients admitted to 20 hospitals in seven Spanish regions during two influenza seasons (2013-2014 and 2014-2015). We included patients aged ≥65 years admitted through the emergency department with a diagnosis compatible with CAP. Patients who died during the initial hospitalisation and those hospitalised more than 30 days were excluded. Finally, 1756 CAP cases were included and of these, 200 (11.39%) were readmitted. 30-day readmission. Factors associated with 30-day readmission were living with a person aged 3 hospital visits during the 90 previous days (aOR 1.53, 95% CI 1.01 to 2.34), chronic respiratory failure (aOR 1.74, 95% CI 1.24 to 2.45), heart failure (aOR 1.69, 95% CI 1.21 to 2.35), chronic liver disease (aOR 2.27, 95% CI 1.20 to 4.31) and discharge to home with home healthcare (aOR 5.61, 95% CI 1.70 to 18.50). No associations were found with pneumococcal or seasonal influenza vaccination in any of the three previous seasons. This study shows that 11.39% of patients aged ≥65 years initially hospitalised for CAP were readmitted within 30 days after discharge. Rehospitalisation was associated with preventable and non-preventable factors.
YR 2018
FD 2018-03-30
LK http://hdl.handle.net/10668/12292
UL http://hdl.handle.net/10668/12292
LA en
DS RISalud
RD Apr 11, 2025